Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Fred E. Cohen currently holds 165,060 shares of UroGen Pharma Ltd. (URGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Fred E. Cohen has been a net seller of URGN stock. They have purchased $0 and sold $5.0M worth of shares.
Fred E. Cohen's most recent insider trade was on Jun 12, 2026, when they sold 9,795 shares at $0.00 per share.
Fred E. Cohen serves as Executive at UroGen Pharma Ltd. (URGN). They have executed 146 insider transactions totaling $5.0M over their tenure at the company.
Fred E. Cohen holds the position of Executive at UroGen Pharma Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Fred E. Cohen has shown a selling trading pattern, with $0 in total purchases and $5.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Fred E. Cohen was on May 18, 2020, when they sold $960.3K worth of VCYT shares. This transaction involved 35,847 shares at $26.79 per share.
Fred E. Cohen currently owns 165,060 shares of UroGen Pharma Ltd. (URGN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Fred E. Cohen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Fred E. Cohen has 146 Form 4 filings on record as an insider at UroGen Pharma Ltd..
Set alerts for Fred E. Cohen and 40,000+ other insiders.